DesmedtJ. E. (1966). Presynaptic mechanisms in myasthenia gravis. Ann. N. Y. Acad. Sci., 135, Art 1, 209.
2.
ElmqvistD. (1965). Neuromuscular transmission with special reference to myasthenia gravis. Acta Physiol, scand., 64, Suppl. 249, 1.
3.
EngelW. K.McFarlinD. E. (1966). Discussion on muscle lesions in myasthenia gravis. Ann. N.Y. Acad. Sci., 135, Art. 1, 68.
4.
FenichelG. M.ShyG. M. (1963). Muscle biopsy experience in myasthenia gravis. Arch. Neurol., 9, 237.
5.
McFarlinD. E.EngelW. K.StraussA. J. L. (1966). Does myasthenic serum bind to the neuromuscular junction?Ann. N.Y. Acad. Sci., 135, Art.1, 656.
6.
MillerJ. F. A. P. (1961). Immunological function of the thymus. Lancet, 2, 748.
7.
NambaT.GrobD. (1966). Autoantibodies and myasthenia gravis, with special reference to muscle ribonucleoprotein. Ann. N.Y. Acad. Sci., 135, Art.1, 606.
8.
SimpsonJ. A. (1958). An evaluation of thymectomy in myasthenia gravis. Brain, 81, 112.
9.
SimpsonJ. A. (1960). Myasthenia gravis: a new hypothesis. Scot. med. J., 5, 419.
10.
SimpsonJ. A. (1964). Immunological disturbances in myasthenia gravis with a report of Hashimoto's disease developing after thymectomy. J. Neurol. Neurosurg. Psychiat., 27, 485.
11.
SimpsonJ. A. (1965). Autoimmunity in myasthenia gravis: raised globulin in blood and C.S.F.Proc. Sth Int. Congr. Neurol., Vienna, Vol. 2 (Neuromuscular Diseases), 541.
12.
SimpsonJ. A. (1966). Myasthenia gravis as an autoimmune disease: clinical aspects. Ann. N.Y. Acad. Sci., 135, Art.1, 506.
13.
StraussA. J. L.SeegalB. C.HsuK. C.BurkholderP.M.NastukW. L.OssermanK. E. (1960). Immunofluorescence demonstration of a muscle binding, complement-fixing serum globulin fraction in myasthenia gravis. Proc. Soc. Exp. Biol. Med., 105, 184.
14.
VettersJ. M. (1965). Immunofluorescence staining patterns in skeletal muscle using serum of myasthenic patients and normal controls. Immunology, 9, 93.